Nonsteroidal anti-inflammatory drug use in patients with chronic kidney disease

[1]  P. Bandosz,et al.  Prevalence of chronic kidney disease in a representative sample of the Polish population: results of the NATPOL 2011 survey. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  A. Derungs [Drug-induced acute kidney injury]. , 2015, Therapeutische Umschau. Revue therapeutique.

[3]  C. Hsiung,et al.  Use of Nonsteroidal Anti-Inflammatory Drugs and Risk of Chronic Kidney Disease in Subjects With Hypertension: Nationwide Longitudinal Cohort Study , 2015, Hypertension.

[4]  J. Fink,et al.  Patient safety issues in CKD: core curriculum 2015. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  J. Vlček,et al.  The impact of combinations of non-steroidal anti-inflammatory drugs and anti-hypertensive agents on blood pressure. , 2014, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[6]  G. Trifirò,et al.  The Burden of Nephrotoxic Drug Prescriptions in Patients with Chronic Kidney Disease: A Retrospective Population-Based Study in Southern Italy , 2014, PloS one.

[7]  J. Liu,et al.  Peptic Ulcer Disease Risk in Chronic Kidney Disease: Ten-Year Incidence, Ulcer Location, and Ulcerogenic Effect of Medications , 2014, PloS one.

[8]  D. Santoro,et al.  Pain in end-stage renal disease: a frequent and neglected clinical problem. , 2012, Clinical nephrology.

[9]  A. Fourrier-Réglat,et al.  Individual NSAIDs and Upper Gastrointestinal Complications , 2012, Drug Safety.

[10]  A. Fourrier-Réglat,et al.  Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). , 2012, Drug safety.

[11]  S. Pavord,et al.  Bleeding and thrombotic complications of kidney disease. , 2011, Blood reviews.

[12]  N. Powe,et al.  Nonsteroidal Anti-Inflammatory Drug Use Among Persons With Chronic Kidney Disease in the United States , 2011, The Annals of Family Medicine.

[13]  Chun-Yuh Yang,et al.  Analgesic use and the risk for progression of chronic kidney disease , 2010, Pharmacoepidemiology and drug safety.

[14]  A. Villa,et al.  Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) México and comparison with KEEP US. , 2010, Kidney international. Supplement.

[15]  C. Huerta,et al.  Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  T. Schnitzer,et al.  A comparison of the efficacy and safety of nonsteroidal antiinflammatory agents versus acetaminophen in the treatment of osteoarthritis: a meta-analysis. , 2004, Arthritis and rheumatism.

[17]  A. Forbes,et al.  Cardiovascular Risk Factors in Patients on Dialysis. , 2015, Nephrology Nursing Journal : Journal of The American Nephrology Nurses Association.